Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
01 1Chunghwa Chemical Synthesis & Biotech. Ltd
02 1Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
03 1BCN PEPTIDES SA
04 1Chengdu Shengnuo Biopharm Co., Ltd.
01 2Lanreotide Acetate
02 1Lanreotide acetate
03 1lanreotide acetate
01 1Spain
02 2Taiwan
03 1U.S.A
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6264
Start Marketing Date : 2019-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6272
Start Marketing Date : 2021-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 35207-0011
Start Marketing Date : 2018-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 32861-0006
Start Marketing Date : 2017-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
38
PharmaCompass offers a list of Lanreotide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lanreotide Acetate manufacturer or Lanreotide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lanreotide Acetate manufacturer or Lanreotide Acetate supplier.
PharmaCompass also assists you with knowing the Lanreotide Acetate API Price utilized in the formulation of products. Lanreotide Acetate API Price is not always fixed or binding as the Lanreotide Acetate Price is obtained through a variety of data sources. The Lanreotide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Somatuline Depot manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Somatuline Depot, including repackagers and relabelers. The FDA regulates Somatuline Depot manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Somatuline Depot API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Somatuline Depot manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Somatuline Depot supplier is an individual or a company that provides Somatuline Depot active pharmaceutical ingredient (API) or Somatuline Depot finished formulations upon request. The Somatuline Depot suppliers may include Somatuline Depot API manufacturers, exporters, distributors and traders.
click here to find a list of Somatuline Depot suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Somatuline Depot as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Somatuline Depot API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Somatuline Depot as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Somatuline Depot and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Somatuline Depot NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Somatuline Depot suppliers with NDC on PharmaCompass.
We have 3 companies offering Somatuline Depot
Get in contact with the supplier of your choice:
